6 ASX stocks hit 52-week lows during market surge

Strong Gains in the ASX 200 Amid Market Rally

The S&P/ASX 200 Index experienced a significant rise today, with shares surging by 2.6% to an intraday peak of 8,804 points during morning trading on Tuesday. This upward movement came as investors shifted their focus away from ongoing geopolitical tensions in Iran and the recent oil price shock.

Among the standout performers, Guzman Y Gomez Ltd (ASX: GYG) saw its shares climb by 18%, while Nextdc Ltd (ASX: NXT) rose by 12%. These gains highlight the positive sentiment in the market, although not all stocks are following this trend.

Stocks at 52-Week Lows

Despite the overall rally, several ASX-listed companies have hit 52-week lows. Here are six such stocks that have struggled in the current market environment:

Sonic Healthcare Ltd (ASX: SHL)

Sonic Healthcare is one of several healthcare companies facing challenges. The sector is grappling with currency fluctuations, US tariffs, and rising operational costs. The share price fell to a decade-low of $18.88 today. Over the past year, the stock has declined by 21%, and it’s down 13% year-to-date. Ord Minnett maintains a hold rating on the company, with a 12-month target of $24.
Stockland Corp Ltd (ASX: SGP)

Stockland’s share price reached a 52-week low of $4.01 today. The stock has dropped 30% year-to-date. A separate article by a colleague, Aaron, explores the reasons behind this decline. Macquarie has reaffirmed its buy rating, with a target price of $4.42.
Endeavour Group Ltd (ASX: EDV)

Endeavour’s shares fell to a record low of $3.13 on Tuesday. The stock has dropped 14% year-to-date. Citi recently downgraded the stock to a hold rating, reducing its 12-month target from $4.30 to $3.70.
Atlas Arteria Group Ltd (ASX: ALX)

Atlas Arteria’s share price hit a nine-year low of $4.21 today. The toll roads operator has seen a 13% decline year-to-date. Morgan Stanley has kept its hold rating but lowered its target from $5.06 to $4.96.
Lendlease Group (ASX: LLC)

Lendlease’s shares dropped to an all-time low of $3.10 on Tuesday. The real estate company has fallen 39% in 2026. Macquarie has maintained its buy rating, with a 12-month target of $4.99.
Healius Ltd (ASX: HLS)

Healius’s share price plummeted to a record low of 51 cents today. The healthcare company has declined 43% year-to-date. Goldman Sachs has reiterated its sell rating, lowering its target from 66 cents to 57 cents.

Considerations for Investors

While the broader market is showing strength, individual stocks can behave differently based on various factors. For instance, Sonic Healthcare, despite being a part of the healthcare sector, has faced significant challenges. Investors considering this stock should carefully evaluate its performance and the outlook for the sector.

For those interested in exploring investment opportunities, there are always other options to consider. Some experts suggest looking at high-yielding dividend shares or stocks that may offer better value. However, it’s essential to conduct thorough research and consult with financial advisors before making any investment decisions.